URA recently announced an agreement with Dexcom, and a new report says this focus on blood sugar monitoring could be a “major ...

It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock ...

You don't need to wait for Apple to add glucose sensing to a smartwatch. Biosensors give you real-time data, and you no ...

Uptake of continuous glucose monitoring (CGM) was relatively low among vulnerable diabetes patients in the largest national ...

On Thursday, DexCom Inc (DXCM) stock saw a decline, ending the day at $74.46 which represents a decrease of $-0.78 or -1.04% from the prior close of $75.24. The stock opened at $74.83 and touched a ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter ...

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eighteen analysts that are covering the stock, Marketbeat reports. Six equities ...

Mutual of America Capital Management LLC grew its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.8% in the 3rd ...

SAN DIEGO & SAN FRANCISCO – Dexcom’s glucose data with be integrated with the Oura Ring’s vital sign, sleep, stress, heart health and activity data to provide users of both products with a more ...

Medical device maker Dexcom is investing $75 million in smart ring maker Oura, opening up opportunities for glucose-tracking ...

The Finnish smart ring maker teamed up with Dexcom, the glucose biosensing system, with the latter making a strategic $75 million investment in Oura at a more than $5 billion valuation. The ...

On Tuesday, DexCom Inc (DXCM) stock saw a decline, ending the day at $74.88 which represents a decrease of $-1.39 or -1.82% from the prior close of $76.27. The stock opened at $75.7 and touched a low ...